Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

Clinical trial NCT01982448 · COMPLETED

Trial details

NCT number: NCT01982448
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2014-04-01
Primary completion: 2019-01-01
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.